T1	condition 24 46	skeletal complications
T2	intervention 80 91	pamidronate
T4	total-participants 482 506	Three hundred eighty-two
T5	control 657 664	placebo
T6	outcome 1789 1797	Survival
T7	outcome 1773 1787	adverse events
T8	outcome 1576 1622	median time to the first skeletal complication
T9	outcome 1338 1375	patients with any pathologic fracture
T10	outcome 1422 1498	need for radiation or surgery to treat bone complications, and hypercalcemia
T11	outcome 1158 1211	proportion of patients with any skeletal complication
T14	iv-cont-median 1627 1638	13.9 months
T15	cv-cont-median 1676 1686	7.0 months
